Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: May 16, 2012; Expiration date: May 16, 2013
Upon completion of this activity, participants will be able to:
• Describe incidence and characteristics of ESBLE infections following liver transplantation, based on a 10-year study
• Describe clinical outcomes of ESBLE infections following liver transplantation, based on a 10-year study
• Describe the effect of ESBLE fecal carriage on risk for ESBLE infections following liver transplantation, and other risk factors for ESBLE infections following liver transplantation.
Shannon O’Connor, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Shannon O’Connor has disclosed no relevant financial relationships.
Laurie Barclay, MD, freelance writer and reviewer, Medscape, LLC. Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.
Disclosures: Frédéric Bert, MD, PhD; Béatrice Larroque, MD, PhD; Federica Dondero, MD; Estelle Marcon; Jacques Belghiti, MD; Richard Moreau, MD; and Marie-Hélène Nicolas-Chanoine, MD, PhD, have disclosed no relevant financial relationships. Catherine Paugam-Burtz, MD, PhD, has disclosed the following relevant financial relationships: served as a speaker or a member of a speakers bureau for Astellas. François Durand, MD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Novartis, Astellas.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: May 17, 2012
- Page last updated: May 17, 2012
- Page last reviewed: May 17, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)